Literature DB >> 18556653

Topoisomerase I requirement for death receptor-induced apoptotic nuclear fission.

Olivier Sordet1, Abby Goldman, Christophe Redon, Stéphanie Solier, V Ashutosh Rao, Yves Pommier.   

Abstract

Topoisomerase I (Top1) is known to relax DNA supercoiling generated by transcription, replication, and chromatin remodeling. However, it can be trapped on DNA as cleavage complexes (Top1cc) by oxidative and carcinogenic DNA lesions, base damage, and camptothecin treatment. We show here that Top1 is also functionally involved in death receptor-induced programmed cell death. In cells exposed to TRAIL or Fas ligand, Top1cc form at the onset of apoptosis. Those apoptotic Top1cc are prevented by caspase inhibition and Bax inactivation, indicating that both caspases and the mitochondrial death pathway are required for their formation. Accordingly, direct activation of the mitochondrial pathway by BH3 mimetic molecules induces apoptotic Top1cc. We also show that TRAIL-induced apoptotic Top1cc are preferentially formed by caspase-3-cleaved Top1 at sites of oxidative DNA lesions with an average of one apoptotic Top1cc/100 kbp. Examination of Top1 knock-down cells treated with TRAIL revealed similar DNA fragmentation but a marked decrease in apoptotic nuclear fission with reduced formation of nuclear bodies. Thus, we propose that Top1 contributes to the full apoptotic responses induced by TRAIL.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18556653      PMCID: PMC2516995          DOI: 10.1074/jbc.M801146200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  61 in total

1.  Altered serine/arginine-rich protein phosphorylation and exonic enhancer-dependent splicing in Mammalian cells lacking topoisomerase I.

Authors:  Johann Soret; Mathieu Gabut; Cecile Dupon; Glenda Kohlhagen; James Stévenin; Yves Pommier; Jamal Tazi
Journal:  Cancer Res       Date:  2003-12-01       Impact factor: 12.701

2.  Topoisomerase I-DNA complexes contribute to arsenic trioxide-induced apoptosis.

Authors:  Olivier Sordet; ZhiYong Liao; Hong Liu; Smitha Antony; Ellen V Stevens; Glenda Kohlhagen; Haiqing Fu; Yves Pommier
Journal:  J Biol Chem       Date:  2004-06-03       Impact factor: 5.157

3.  Extranuclear detection of histones and nucleosomes in activated human lymphoblasts as an early event in apoptosis.

Authors:  C Gabler; N Blank; T Hieronymus; M Schiller; J H M Berden; J R Kalden; H-M Lorenz
Journal:  Ann Rheum Dis       Date:  2004-09       Impact factor: 19.103

4.  The human topoisomerase I damage response plays a role in apoptosis.

Authors:  Kent Søe; Anja Rockstroh; Peter Schache; Frank Grosse
Journal:  DNA Repair (Amst)       Date:  2004-04-01

5.  DNA topoisomerase I is involved in both repression and activation of transcription.

Authors:  A Merino; K R Madden; W S Lane; J J Champoux; D Reinberg
Journal:  Nature       Date:  1993-09-16       Impact factor: 49.962

6.  Hydrogen peroxide induces topoisomerase I-mediated DNA damage and cell death.

Authors:  Parima Daroui; Shyamal D Desai; Tsai-Kun Li; Angela A Liu; Leroy F Liu
Journal:  J Biol Chem       Date:  2003-12-19       Impact factor: 5.157

7.  Nonclassic functions of human topoisomerase I: genome-wide and pharmacologic analyses.

Authors:  Ze-Hong Miao; Audrey Player; Uma Shankavaram; Yong-Hong Wang; Drazen B Zimonjic; Philip L Lorenzi; Zhi-Yong Liao; Hong Liu; Tsutomu Shimura; Hong-Liang Zhang; Ling-Hua Meng; Yong-Wei Zhang; Ernest S Kawasaki; Nicholas C Popescu; Mirit I Aladjem; David J Goldstein; John N Weinstein; Yves Pommier
Journal:  Cancer Res       Date:  2007-09-15       Impact factor: 12.701

8.  In vitro and in vivo effects of clinically important camptothecin analogues on multidrug-resistant cells.

Authors:  M R Mattern; G A Hofmann; R M Polsky; L R Funk; F L McCabe; R K Johnson
Journal:  Oncol Res       Date:  1993       Impact factor: 5.574

9.  Disruption of mitochondrial function during apoptosis is mediated by caspase cleavage of the p75 subunit of complex I of the electron transport chain.

Authors:  Jean-Ehrland Ricci; Cristina Muñoz-Pinedo; Patrick Fitzgerald; Béatrice Bailly-Maitre; Guy A Perkins; Nagendra Yadava; Immo E Scheffler; Mark H Ellisman; Douglas R Green
Journal:  Cell       Date:  2004-06-11       Impact factor: 41.582

10.  Caspase-mediated loss of mitochondrial function and generation of reactive oxygen species during apoptosis.

Authors:  Jean-Ehrland Ricci; Roberta A Gottlieb; Douglas R Green
Journal:  J Cell Biol       Date:  2003-01-06       Impact factor: 10.539

View more
  7 in total

1.  Genome-wide analysis of novel splice variants induced by topoisomerase I poisoning shows preferential occurrence in genes encoding splicing factors.

Authors:  Stéphanie Solier; Jennifer Barb; Barry R Zeeberg; Sudhir Varma; Mike C Ryan; Kurt W Kohn; John N Weinstein; Peter J Munson; Yves Pommier
Journal:  Cancer Res       Date:  2010-09-03       Impact factor: 12.701

2.  8-Oxo-7,8-dihydroguanine: links to gene expression, aging, and defense against oxidative stress.

Authors:  Zsolt Radak; Istvan Boldogh
Journal:  Free Radic Biol Med       Date:  2010-05-17       Impact factor: 7.376

Review 3.  Pheochromocytoma and paraganglioma: diagnosis, genetics, management, and treatment.

Authors:  Victoria L Martucci; Karel Pacak
Journal:  Curr Probl Cancer       Date:  2014-01-15       Impact factor: 3.187

Review 4.  The nuclear γ-H2AX apoptotic ring: implications for cancers and autoimmune diseases.

Authors:  Stéphanie Solier; Yves Pommier
Journal:  Cell Mol Life Sci       Date:  2014-01-22       Impact factor: 9.261

5.  Neutral Porphyrin Derivative Exerts Anticancer Activity by Targeting Cellular Topoisomerase I (Top1) and Promotes Apoptotic Cell Death without Stabilizing Top1-DNA Cleavage Complexes.

Authors:  Subhendu K Das; Arijit Ghosh; Srijita Paul Chowdhuri; Nyancy Halder; Ishita Rehman; Souvik Sengupta; Krushna Chandra Sahoo; Harapriya Rath; Benu Brata Das
Journal:  J Med Chem       Date:  2018-01-11       Impact factor: 7.446

6.  Copy-number variation of cancer-gene orthologs is sufficient to induce cancer-like symptoms in Saccharomyces cerevisiae.

Authors:  Michaela de Clare; Stephen G Oliver
Journal:  BMC Biol       Date:  2013-03-25       Impact factor: 7.431

7.  Executioner caspases and CAD are essential for mutagenesis induced by TRAIL or vincristine.

Authors:  Mark A Miles; Christine J Hawkins
Journal:  Cell Death Dis       Date:  2017-10-05       Impact factor: 8.469

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.